Alembic Pharmaceuticals Limited — Important, 18-06-2025: General Updates

Alembic Pharmaceuticals has announced a board meeting to review the financial results for the quarter and half-year. The company received the Establishment Inspection Report from the USFDA for its API-III facility at Karakhadi, following a recent inspection. This clearance supports continued compliance with key regulatory standards, potentially aiding its API business growth and export prospects. No financial impact was disclosed.